P, K. et al. 2025. Adjunct Synbiotic Therapy with Vildagliptin–Metformin Improves Glycemic Control, Insulin Sensitivity, and Cost-Efficiency in Elderly Patients with Type 2 Diabetes: Adjunct Synbiotic Therapy with Vildagliptin–Metformin. Asian Journal of Pharmaceutical and Clinical Research. 19, 1 (Dec. 2025).